Product Information
PIOGLITAZONE HCL 30 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0903 per EA under NDC 00093727256. Its NADAC has been published 589 times since May 13, 2015.
FDA first approved this application on Jan 10, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093727256
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PIOGLITAZONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077210FDA Approved
1/10/2014
TE Code
AB
On Market Since
2/4/2015
Pharmacological Classes
Price Statistics
The NADAC for PIOGLITAZONE HCL 30 MG TABLET has been published 589 times since May 13, 2015, and over the history we have for it it has declined 61.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0903 per EA |
|---|---|
| All-time high | $0.2319 (May 13, 2015) |
| All-time low | $0.0828 (Nov 20, 2024) |
| 52-week high | $0.0981 |
| 52-week low | $0.0888 |
| Median price | $0.1233 |
| Average price | $0.1361 |
| Largest weekly change | +24.7% (Jun 19, 2024) |
| Weeks tracked | 589 |
| Tracking since | May 13, 2015 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PIOGLITAZONE HCL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE HCL 30 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0903 per EA (NDC 00093727256), effective Aug 19, 2026.
How has the price of PIOGLITAZONE HCL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for PIOGLITAZONE HCL 30 MG TABLET has declined 61.1%. It has been tracked across 589 weekly CMS publications since May 13, 2015.
What are the highest and lowest recorded NADAC prices for PIOGLITAZONE HCL 30 MG TABLET?
Since May 13, 2015, the NADAC for PIOGLITAZONE HCL 30 MG TABLET has ranged from a low of $0.0828 (Nov 20, 2024) to a high of $0.2319 (May 13, 2015), with a median of $0.1233 per EA.
Are there cheaper alternatives to PIOGLITAZONE HCL 30 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PIOGLITAZONE HCL 30 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PIOGLITAZONE HCL 30 MG TABLET?
PIOGLITAZONE HCL 30 MG TABLET (NDC 00093727256) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.